ARID1A and gastric cancer: Knockdown of ARID1A in gastric cancer cell lines led to reduced E-cadherin (CDH1) expression, disruption of the cadherin/catenin complex, epithelial–mesenchymal transition, and enhanced invasive properties of the cells [88].